How We’re Mobilizing Our Resources to Help Find Solutions for Covid-19
Learn More
Share
Health Workforce
very health worker trained and supported helps to build a stronger community, and every enhanced community brings the world one step closer toward achieving good health and well-being for all. A robust, trained and motivated healthcare workforce is critical to saving and improving the lives of women, children and their families while also improving national health outcomes. For decades, Johnson & Johnson has worked to strengthen the people at the front lines of delivering care. From getting young people interested in healthcare as a career, to supporting their clinical training as future front-line health workers and caregivers, we help to ensure they have the skills they need to improve and save lives.
Our Aspiration: A world where the current and future health care workforce has the necessary competencies to deliver high quality health care.
5-Year Target: 650,000 health workers will have received training to better deliver quality health care.
Our Impact:
• How a Partnership Between the U.S. and China Saved Thousands of Babies
• Celebrating a Decade of Johnson & Johnson Partnership with mothers2mothers
• Connecting Hard to Reach Populations with Health
Related Content
December 04, 2016
Meet three young women from China, Mexico and South Africa who are carrying this age-old tradition into the 21st century.
October 05, 2016
It was an historic initiative: train healthcare workers across China in neonatal resuscitation. We go behind the scenes to explore the secrets of the program’s success.
January 31, 2017
In 2011, Johnson & Johnson made a $2 million 5-year investment in the Helping Babies Breathe (HBB) initiative in Malawi and Uganda. The program, implemented by Save the Children in these two countries, aims to reduce neonatal mortality due to birth asphyxia by integrating neonatal resuscitation skills and equipment within existing maternal and newborn health services. By 2015, the partnership had supported HBB training of more than 1,300 skilled birth attendants and saved nearly 23,000 babies (90% of asphyxiated babies) in Malawi and Uganda. Designed for national scale-up by Ministries of Health in the longer term, the project also focuses on improved data reporting and use of data for decision-making in existing J&J supported sites.
January 31, 2017
Across Africa, there is a growing recognition that fostering a new cadre of leaders with strong management and leadership expertise will help strengthen the capacity of health systems, boost the quality, quantity and access to health services for underserved populations, and help countries achieve their national health priorities. As Julio Frenk, Dean of Faculty at the Harvard T.H. Chan School of Public Health points out, “Professionals are falling short on appropriate competencies for effective teamwork, and they are not exercising effective leadership to transform health systems.”
June 20, 2017
This Johnson & Johnson program pairs high school kids with local companies and institutes of higher learning to help set them up for success in the work world. We take a look at the inspiring statistics behind that success.
June 06, 2016
I have often been told that I don’t look like a mechanical engineer, but I love calculus, taking things apart to find out how they work and thermodynamics. Fortunately, I grew up in a supportive environment where my parents and teachers encouraged these passions.
Johnson & Johnson has signed up to the 2030 UN Sustainable Development Goals—the world’s road map for progress.
More From Johnson & Johnson
Chairman & CEO Alex Gorsky shares that the company could have the first batches of a Covid-19 vaccine available for emergency-use authorization in early 2021—a substantially accelerated time frame in comparison to the typical vaccine development process.
Imagine being a researcher who is staring down not only a highly infectious virus, but one that's caused the first global pandemic in more than 100 years. Meet Johnson & Johnson's Hanneke Schuitemaker, Ph.D.
Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.
